Oncopeptides is stepping into one of oncology’s toughest challenges – glioblastoma (malignant brain tumor) – a topic we explore in the latest episode of Oncopeptalks.
In this conversation, CEO Sofia Heigis, CMO Stefan Norin, and COO Eva Nordström share their insights on why Oncopeptides’ PDC platform could make a difference where so many others have failed.
Podcast in Swedish, follow this link for transcripts in Swedish and English:
https://oncopeptalks.vercel.app/
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
